new bacterial infection 2021 :: Article Creator Acute Bacterial Skin And Skin-Structure Infection (ABSSSI) Market: Insights Into Epidemiology, Treatments, And Key CompaniesMicuRx, Basilea Pharmaceuticals, AbbVie, Cubist ... "Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Market" As per secondary analysis, ABSSSI accounted for almost 870,000 hospital admissions in the United States in 2004 which represents an increase of almost 30% in the incidence of this diagnosis over a 4-year period. Emerging therapies for acute bacterial skin and skin-structure infections (ABSSSI), including DALVANCE (dalbavancin), ORBACTIV, MRX-4, ZEVTERA (ceftobiprole), and others, are anticipated to drive growth in the ABSSSI market in the coming years. DelveInsight has published a new report titled "Acute Bacterial Skin and Skin-Structure Infection – Market Insights, Epidemiology, and Market Forecast–2034", providing a comprehensive analysis o...